Gelonghui October 25th | Boji Medical Technology (300404.SZ) announced its third quarter report for 2024, with the company achieving revenue of 0.556 billion yuan in the first three quarters, a year-on-year increase of 55.01%; net income attributable to the shareholders of the listed company was 43.2778 million yuan, a year-on-year increase of 87.98%; net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 34.8898 million yuan, a year-on-year increase of 155.65%; basic earnings per share was 0.1133 yuan.
博济医药(300404.SZ):前三季度净利润4327.78万元 同比增长87.98%
Boji Medical Technology (300404.SZ): The net income for the first three quarters was 43.2778 million yuan, an 87.98% year-on-year increase.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.